Anti-CAP1 Antibody

This polyclonal antibody from Antibodies.com targets CAP1 (Adenylyl Cyclase-Associated Protein 1), a highly conserved actin-binding regulator that controls cytoskeletal remodeling, cell motility, and receptor-mediated signaling cascades. Raised in rabbit hosts and supplied as an unconjugated reagent in a 100 µl vial, the antibody is validated for Western blot (WB) and immunohistochemistry (IHC) workflows against human samples, supporting studies in cancer cell invasion, immune cell chemotaxis, and actin-driven morphogenesis.

CAP1 coordinates actin filament turnover through its C-terminal domain and participates in cyclic-AMP regulation via its N-terminal interaction with adenylyl cyclase, making this reagent useful for dissecting pathways linked to metastasis, macrophage activation, and cytoskeletal reorganization. Researchers commonly deploy this antibody on paraffin-embedded tissue sections and nitrocellulose membranes to map CAP1 expression across tumor and normal tissue panels.